Clinical trials
Withdrawn Phase 1 Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| OHSU Knight Cancer Institute | 3 |
| University of Alabama at Birmingham | 3 |
| AbbVie | 1 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Beijing Kejing Biotechnology Co., Ltd. | 1 |
| Case Comprehensive Cancer Center | 1 |
| Haider Mahdi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 30 |
| Breast Neoplasms | 9 |
| Fallopian Tube Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Pancreatic Neoplasms | 5 |
| Endometrial Neoplasms | 4 |
| Stomach Neoplasms | 4 |
| Triple Negative Breast Neoplasms | 4 |
| Carcinoma, Ovarian Epithelial | 3 |
| Lung Neoplasms | 3 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.